Second Alzheimer's drug to slow disease's progression may be approved in the US this year | Health

(CNN) — The full approval this month of the Alzheimer’s drug Leqembi marked a historic shift in the treatment of the disease: For the first time, doctors have a medicine

Related Keywords

Wisconsin ,United States ,California ,San Francisco ,Americans ,American ,Los Angeles ,Eli Lilly ,Eric Widera ,Nathaniel Chin ,Sharon Brangman ,Daniel Skovronsky ,Lawrence Honig ,Joe Montminy ,Gil Rabinovici ,University Of Wisconsin Dr ,University Of California ,Cnn ,Warner Bros ,Discovery Company ,Drug Administration ,Cable News Network Inc ,Columbia University Irving Medical Center ,University Dr ,Alzheimer Association International Conference On ,Journal Of The American Medical Association ,Association International Conference ,American Medical Association ,Kacie Deters ,Disease Rating Scale ,Clinical Dementia Rating Sum ,Medical University ,News Network ,